Clincosm LogoSign in Get a demo

amyotrophic lateral sclerosis (als)

Showing 1 - 25 of 54
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Parkinson Disease Psychosis, Amyotrophic Lateral Sclerosis (ALS) Trial (FB418)

Not yet recruiting
  • Parkinson Disease Psychosis
  • Amyotrophic Lateral Sclerosis (ALS)
  • (no location specified)
Aug 13, 2023

Amyotrophic Lateral Sclerosis (ALS) Trial in Worldwide (Tauroursodeoxycholic Acid, Placebo)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis (ALS)
  • Tauroursodeoxycholic Acid
  • Placebo
  • Leuven, Belgium
  • +24 more
Oct 17, 2022

Amyotrophic Lateral Sclerosis (ALS), Neuromuscular Diseases Trial in Gainesville (Acute Intermittent Hypoxia, Sham Acute

Recruiting
  • Amyotrophic Lateral Sclerosis (ALS)
  • Neuromuscular Diseases
  • Acute Intermittent Hypoxia
  • Sham Acute Intermittent Hypoxia
  • Gainesville, Florida
  • +1 more
Jul 25, 2022

Amyotrophic Lateral Sclerosis (ALS) Trial in Stanford (18F-OP-801)

Not yet recruiting
  • Amyotrophic Lateral Sclerosis (ALS)
  • Stanford, California
    Stanford University
May 25, 2022

Circulating Biomarker for Amyotrophic Lateral Sclerosis (ALS)

Recruiting
  • Amyotrophic Lateral Sclerosis (ALS)
    • Pozzilli, Italy
      IRCCS Neuromed
    May 18, 2022

    Amyotrophic Lateral Sclerosis (ALS) Trial in Dallas (Antioxidants)

    Recruiting
    • Amyotrophic Lateral Sclerosis (ALS)
    • Antioxidants
    • Dallas, Texas
      VA North Texas Health Care System
    Mar 25, 2022

    Amyotrophic Lateral Sclerosis (ALS) Trial (PU-AD, Placebo)

    Withdrawn
    • Amyotrophic Lateral Sclerosis (ALS)
    • (no location specified)
    Mar 22, 2022

    Innovative Measures of Speech and Swallowing Dysfunction in

    Recruiting
    • Amyotrophic Lateral Sclerosis (ALS)
    • +4 more
      • Boston, Massachusetts
        Beth Israel Deaconess Medical Center
      Mar 10, 2022

      Amyotrophic Lateral Sclerosis (ALS) Trial in Lebanon (L-Serine)

      Recruiting
      • Amyotrophic Lateral Sclerosis (ALS)
      • Lebanon, New Hampshire
        Dartmouth-Hitchcock Medical Center
      Feb 22, 2022

      DNA, Blood and Skin Cell Repository for Research on ALS and

      Completed
      • Amyotrophic Lateral Sclerosis (ALS)
        • Jacksonville, Florida
          Mayo Clinic Florida
        Feb 14, 2022

        Amyotrophic Lateral Sclerosis (ALS) Trial in United States (NurOwn® (MSC-NTF cells), Placebo, Bone Marrow aspiration)

        Completed
        • Amyotrophic Lateral Sclerosis (ALS)
        • NurOwn® (MSC-NTF cells)
        • +2 more
        • Irvine, California
        • +5 more
        Oct 5, 2021

        Amyotrophic Lateral Sclerosis (ALS) Trial in Limoges (Oral nutritional supplementation)

        Completed
        • Amyotrophic Lateral Sclerosis (ALS)
        • Oral nutritional supplementation
        • Limoges, France
          Service de Neurologie
        Aug 18, 2021

        Frontotemporal Lobar Degeneration (ARTFL)

        Completed
        • FTLD
        • +11 more
          • Birmingham, Alabama
          • +16 more
          May 18, 2021

          Amyotrophic Lateral Sclerosis (ALS) Trial in New York (Sleep study-guided adjustment of NIV, Standard initiation of NIV)

          Terminated
          • Amyotrophic Lateral Sclerosis (ALS)
          • Sleep study-guided adjustment of NIV
          • Standard initiation of NIV
          • New York, New York
            Columbia University Medical Center
          Nov 10, 2020

          F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral

          Completed
          • Amyotrophic Lateral Sclerosis (ALS)
          • Drug: F 18 T807
          • Saint Louis, Missouri
            Washington University School of Medicine
          Sep 17, 2020

          Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis

          Completed
          • Amyotrophic Lateral Sclerosis (ALS)
          • [18F] GE-180
          • Boston, Massachusetts
          • +1 more
          May 19, 2020

          Amyotrophic Lateral Sclerosis (ALS) Trial in United States (NeuRx Diaphragm Pacing System (DPS))

          Completed
          • Amyotrophic Lateral Sclerosis (ALS)
          • NeuRx Diaphragm Pacing System (DPS)
          • Los Angeles, California
          • +10 more
          Mar 25, 2020

          Amyotrophic Lateral Sclerosis (ALS) Trial in Montreal (Non-invasive home ventilation)

          Completed
          • Amyotrophic Lateral Sclerosis (ALS)
          • Non-invasive home ventilation
          • Montreal, Quebec, Canada
            Montreal Chest Institute
          Feb 20, 2020

          Amyotrophic Lateral Sclerosis (ALS) Trial in United States (Rasagiline, Placebo)

          Completed
          Has Results
          • Amyotrophic Lateral Sclerosis (ALS)
          • Phoenix, Arizona
          • +9 more
          Jan 14, 2020

          Mild Cognitive Impairment (MCI), Alzheimer (AD), Dementia With Lewy Bodies (DLB) Trial in Minneapolis (Neuraceq)

          Withdrawn
          • Mild Cognitive Impairment (MCI)
          • +10 more
          • Neuraceq
          • Minneapolis, Minnesota
            University of Minnesota
          Nov 6, 2019

          Amyotrophic Lateral Sclerosis (ALS) Trial in Jerusalem (IPL344)

          Recruiting
          • Amyotrophic Lateral Sclerosis (ALS)
          • Jerusalem, Israel
          • +1 more
          Sep 6, 2019

          A Biospecimen and Clinical Data Study on Alzheimer's, Multiple

          Completed
          • Alzheimer's Disease
          • +4 more
            • Sherman Oaks, California
              Sanguine Biosciences
            Apr 4, 2019

            Amyotrophic Lateral Sclerosis (ALS) Trial in Osaka (MCI-186, Placebo, MCI-186 in open label phase)

            Completed
            Has Results
            • Amyotrophic Lateral Sclerosis (ALS)
            • Osaka, Japan
              (unnamed)
            Jun 26, 2018

            Amyotrophic Lateral Sclerosis (ALS) Trial in Madrid (Masitinib (4.5), Riluzole, Placebo)

            Completed
            • Amyotrophic Lateral Sclerosis (ALS)
            • Masitinib (4.5)
            • +3 more
            • Madrid, Spain
              Hospital Carlos III
            Dec 13, 2018

            Spinal Cord Injury (SCI), Amyotrophic Lateral Sclerosis (ALS) Trial in Bronx (Transcranial magnetic stimulation, Median nerve

            Completed
            • Spinal Cord Injury (SCI)
            • Amyotrophic Lateral Sclerosis (ALS)
            • Transcranial magnetic stimulation
            • +2 more
            • Bronx, New York
              James J. Peters VA Medical Center, Bronx, NY
            Sep 28, 2018